Cary J Claiborne
CIK 1370930 · Chief Executive Officer · last filed 2026-04-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$120.4K
Companies
6
Total Filings
43
Lifetime Open-Market Net
-$706.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADIL | Chief Executive Officer | 40,417 | $2.98 | $120.4K | $0 | 4 | 2026-04-09 |
| ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Chief Executive Officer | 1,520,000 | $0.00 | $1.4K | $0 | 6 | 2023-05-25 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Chief Financial Officer | 45,764 | — | — | -$734.6K | 18 | 2014-12-17 |
| New Generation Biofuels Holdings, Inc (NGBF) Delisted | CEO, CFO and President | 283,179 | — | — | $28.2K | 9 | 2009-12-29 |
| New Generation Biofuels Holdings, Inc (GNB) Delisted | Chief Financial Officer | 10,236 | — | — | $0 | 1 | 2008-06-06 |
| OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | Chief Financial Officer | 75,000 | — | — | $0 | 3 | 2007-11-23 |
Recent Filings · Page 2 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-03 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-17 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Mixed | — | -$441.9K | EDGAR |
| 2014-09-15 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-07-10 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +267 | $1.8K | EDGAR |
| 2014-07-10 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +220 | $1.5K | EDGAR |
| 2014-02-28 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Mixed | — | -$12.3K | EDGAR |
| 2014-01-09 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Mixed | — | -$11.5K | EDGAR |
| 2014-01-06 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +196 | $1.8K | EDGAR |
| 2013-11-26 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Exer (X) | −16,500 | -$125.4K | EDGAR |
| 2013-10-01 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +253 | $1.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.